What is the benefit of aggressive chemotherapy for advanced neuroblastoma with N-myc amplification? A report from the Japanese study group for the treatment of advanced neuroblastoma
- 30 June 1994
- journal article
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 29 (6) , 746-750
- https://doi.org/10.1016/0022-3468(94)90360-3
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Detection of specific sequences among DNA fragments separated by gel electrophoresisPublished by Elsevier ,2006
- Toxicity of single-day high-dose vincristine, melphalan, etoposide and carboplatin consolidation with autologous bone marrow rescue in advanced neuroblastomaEuropean Journal Of Cancer, 1992
- Improved survival rates in children over 1 year of age with stage III or IV neuroblastoma following an intensive chemotherapeutic regimenJournal of Pediatric Surgery, 1989
- Flow cytometric DNA analysis of Neuroblastoma and Ganglioneuroma. A 10-year retrospective studyCancer, 1988
- Association of Multiple Copies of the N-mycOncogene with Rapid Progression of NeuroblastomasNew England Journal of Medicine, 1985
- Histopathologic Prognostic Factors in Neuroblastic Tumors: Definition of Subtypes of Ganglioneuroblastoma and an Age-Linked Classification of NeuroblastomasJNCI Journal of the National Cancer Institute, 1984
- Results in children with local and regional neuroblastoma managed with and without vincristine, cyclophosphamide, and imidazolecarboxamideAmerican Journal of Clinical Oncology, 1984
- Chemotherapy of advanced neuroblastoma: does adriamycin contribute?Archives of Disease in Childhood, 1981
- Intensive chemotherapy for metastatic neuroblastoma: A southwest oncology group studyMedical and Pediatric Oncology, 1980
- Multiagent chemotherapy for children with metastatic neuroblastoma: A report from childrens cancer study groupMedical and Pediatric Oncology, 1979